<DOC>
	<DOCNO>NCT00715390</DOCNO>
	<brief_summary>To describe type incidence cardiac dysrhythmias occur anesthesia present anesthesia environment .</brief_summary>
	<brief_title>Dysrhythmias During General Anesthesia Children</brief_title>
	<detailed_description>It unclear current state anesthesia associate dysrhythmias pediatric population . This last investigated retrospectively 1992 predominant volatile agent use inhalation induction halothane . Sevoflurane approve Food Drug Administration 1995 . Since time , Sevoflurane displace halothane agent choice inhalation induction relegate halothane use narrow niche primarily involve patient specific congenital heart diseases . It describe halothane large proarrhythmic effect sevoflurane ventricular dysrhythmias . With transition halothane sevoflurane era , reassessment incidence type dysrhythmias occur non-cardiac pediatric patient important .</detailed_description>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Children , anesthesia , 1. circumstance tachycardia bradycardia , 2. administration medication use treatment dysrhythmias , 3. commentary include comment heart rhythm therapy dysrhythmia , 4. quality assurance database evidence dysrhythmia Children know preoperative : 1. prior history dysrhythmia and/or 2. residual congenital heart disease 3. anti/pro dysrhythmic medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Children</keyword>
	<keyword>Cardiac Arrhythmia</keyword>
	<keyword>General Anesthesia</keyword>
</DOC>